Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3′-deamino-3′-aziridinyl-4′-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validation
- Resource Type
- Article
- Source
- In
European Journal of Cancer March 2003 39(5):675-683 - Subject
- Language
- ISSN
- 0959-8049